Global Point of Care

Determine™ HIV-1/2 Ag/Ab Combo

The first FDA approved rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen. This antigen/antibody test (4th generation) has the ability to identify HIV earlier than antibody-only tests (2nd and 3rd generation).1 It enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner.

Only available in the US.

1. Masciotra, S, et al. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast. J Clin Virol 2013: Published online 05 August 2013. DOI: 10.1016/j.jcv.2013.07.002

2. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibodyseroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871-1879.

*Average shelf life received by customer (product has a 15 month shelf life from date of manufacture)
**From date of manufacture